A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation
- PMID: 30847170
- PMCID: PMC6388501
- DOI: 10.3892/mco.2019.1795
A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation
Abstract
MicroRNAs (miRNAs/miRs) are a novel class of gene regulators that may be involved in tumor chemoresistance. Recently, specific miRNA expression profiles have been identified in adult glioblastoma (aGBM), but there are only limited data available on the role of miRNAs in pediatric GBM (pGBM). In the present study, the expression profile of miRNAs was examined in seven pGBMs and three human GBM cell lines (U87MG, A172 and T98G), compared with a non-tumoral pool of pediatric cerebral cortex samples by microarray analysis. A set of differentially expressed miRNAs was identified, including miR-490, miR-876-3p, miR-876-5p, miR-448 and miR-137 (downregulated), as well as miR-501-3p (upregulated). Through bioinformatics analysis, a series of target genes was predicted. In addition, similar gene expression patterns in pGBMs and cell lines was confirmed. Of note, drug resistant T98G cells had upregulated nuclear casein kinase and cyclin-dependent kinase substrate 1 (NUCKS1) expression, a protein overexpressed in many tumors that serves an important role in cell proliferation and progression. On the basis of the present preliminary report, it could be intriguing to further investigate the relationship between each of the identified differentially expressed miRNAs and NUCKS1, in order to clarify their involvement in the multi-drug resistance mechanism of pGBMs.
Keywords: gene; glioblastoma multiforme; high-grade glioma; microRNAs; pediatric brain tumor.
Figures


Similar articles
-
Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing apoptosis.Am J Cancer Res. 2014 Dec 15;5(1):231-42. eCollection 2015. Am J Cancer Res. 2014. PMID: 25628933 Free PMC article.
-
MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.Tumour Biol. 2016 Jun;37(6):7719-27. doi: 10.1007/s13277-015-4654-x. Epub 2015 Dec 21. Tumour Biol. 2016. PMID: 26692101
-
High-throughput microRNA profile in adult and pediatric primary glioblastomas: the role of miR-10b-5p and miR-630 in the tumor aggressiveness.Mol Biol Rep. 2020 Sep;47(9):6949-6959. doi: 10.1007/s11033-020-05754-3. Epub 2020 Sep 4. Mol Biol Rep. 2020. PMID: 32888124
-
Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells.Brain Sci. 2023 Feb 18;13(2):350. doi: 10.3390/brainsci13020350. Brain Sci. 2023. PMID: 36831894 Free PMC article.
-
Shift of microRNA profile upon glioma cell migration using patient-derived spheroids and serum-free conditions.J Neurooncol. 2017 Mar;132(1):45-54. doi: 10.1007/s11060-016-2356-x. Epub 2017 Jan 13. J Neurooncol. 2017. PMID: 28091986 Free PMC article.
Cited by
-
SATB1 in cancer progression and metastasis: mechanisms and therapeutic potential.Front Oncol. 2025 Feb 25;15:1535929. doi: 10.3389/fonc.2025.1535929. eCollection 2025. Front Oncol. 2025. PMID: 40071088 Free PMC article. Review.
-
Functional association between NUCKS1 gene and Parkinson disease: A potential susceptibility biomarker.Bioinformation. 2019 Sep 5;15(8):548-556. doi: 10.6026/97320630015548. eCollection 2019. Bioinformation. 2019. PMID: 31719764 Free PMC article.
-
miR-641 Inhibited Cell Proliferation and Induced Apoptosis by Targeting NUCKS1/PI3K/AKT Signaling Pathway in Breast Cancer.Comput Math Methods Med. 2022 Jan 12;2022:5203839. doi: 10.1155/2022/5203839. eCollection 2022. Comput Math Methods Med. 2022. PMID: 35069784 Free PMC article.
-
MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.Hum Cell. 2021 Mar;34(2):624-633. doi: 10.1007/s13577-020-00468-x. Epub 2021 Jan 7. Hum Cell. 2021. PMID: 33415690
-
MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level.Am J Transl Res. 2020 Aug 15;12(8):4749-4756. eCollection 2020. Am J Transl Res. 2020. PMID: 32913547 Free PMC article.
References
-
- Pollack IF, Hamilton RL, James CD, Finkelstein SD, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL. Children's Oncology Group: Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: Results from the Children's Cancer Group 945 cohort. J Neurosurg. 2006;105(Suppl 5):S418–S424. - PubMed
-
- Pollack IF, Boyett JM, Yates AJ, Burger PC, Gilles FH, Davis RL, Finlay JL. Children's Cancer Group: The influence of central review on outcome associations in childhood malignant gliomas: Results from the CCG-945 experience. Neuro Oncol. 2003;5:197–207. doi: 10.1215/S1152851703000097. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources